Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study - Cohoon, K P; De Sanctis, Y; Haskell, L; McBane, R D; Spiro, T E (J Thromb Haemost, 2018)